A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.
about
Celecoxib for osteoarthritis.Osteoarthritis year in review 2015: clinical.Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial.Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats.
P2860
A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A cost-effectiveness analysis ...... aptation of the NICE OA model.
@en
A cost-effectiveness analysis ...... ment of pain in osteoarthritis
@nl
type
label
A cost-effectiveness analysis ...... aptation of the NICE OA model.
@en
A cost-effectiveness analysis ...... ment of pain in osteoarthritis
@nl
prefLabel
A cost-effectiveness analysis ...... aptation of the NICE OA model.
@en
A cost-effectiveness analysis ...... ment of pain in osteoarthritis
@nl
P2093
P1476
A cost-effectiveness analysis ...... aptation of the NICE OA model.
@en
P2093
Mats Ekelund
Nicholas Brereton
Ronald Akehurst
P304
P356
10.3111/13696998.2014.933111
P407
P577
2014-06-30T00:00:00Z